Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non–Small-cell Lung Cancer
Titel:
Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non–Small-cell Lung Cancer
Auteur:
Bordoni, Rodolfo Ciardiello, Fortunato von Pawel, Joachim Cortinovis, Diego Karagiannis, Thomas Ballinger, Marcus Sandler, Alan Yu, Wei He, Pei Matheny, Christina Felizzi, Federico Rittmeyer, Achim